home / stock / cmnd:cc / cmnd:cc quote
Last: | $0.385 |
---|---|
Change Percent: | 0.0% |
Open: | $0.385 |
Close: | $0.385 |
High: | $0.385 |
Low: | $0.385 |
Volume: | 4,197 |
Last Trade Date Time: | 05/06/2022 04:56:59 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.385 | $0.385 | $0.385 | $0.385 | $0.385 | 4,197 | 05-06-2022 |
$0.4 | $0.395 | $0.4 | $0.4 | $0.395 | 3,261 | 05-04-2022 |
$0.39 | $0.4 | $0.39 | $0.4 | $0.39 | 11,563 | 05-02-2022 |
$0.39 | $0.33 | $0.39 | $0.39 | $0.33 | 35,962 | 04-29-2022 |
$0.34 | $0.385 | $0.34 | $0.385 | $0.32 | 19,376 | 04-28-2022 |
$0.35 | $0.35 | $0.35 | $0.35 | $0.35 | 3,081 | 04-27-2022 |
$0.35 | $0.34 | $0.35 | $0.35 | $0.34 | 3,500 | 04-26-2022 |
$0.34 | $0.34 | $0.34 | $0.34 | $0.34 | 1,241 | 04-25-2022 |
$0.395 | $0.35 | $0.395 | $0.395 | $0.35 | 3,030 | 04-22-2022 |
$0.335 | $0.37 | $0.335 | $0.37 | $0.33 | 14,832 | 04-21-2022 |
$0.36 | $0.375 | $0.36 | $0.375 | $0.36 | 10,500 | 04-20-2022 |
$0.38 | $0.38 | $0.38 | $0.425 | $0.375 | 12,082 | 04-19-2022 |
$0.37 | $0.39 | $0.37 | $0.4 | $0.35 | 59,866 | 04-15-2022 |
$0.37 | $0.39 | $0.37 | $0.4 | $0.35 | 49,866 | 04-14-2022 |
$0.42 | $0.44 | $0.42 | $0.44 | $0.4 | 14,476 | 04-13-2022 |
$0.44 | $0.44 | $0.44 | $0.44 | $0.44 | 1,105 | 04-12-2022 |
$0.47 | $0.445 | $0.47 | $0.47 | $0.445 | 33,921 | 04-08-2022 |
$0.425 | $0.415 | $0.425 | $0.425 | $0.415 | 5,801 | 04-07-2022 |
$0.41 | $0.41 | $0.41 | $0.445 | $0.4 | 29,310 | 04-06-2022 |
$0.41 | $0.41 | $0.41 | $0.45 | $0.41 | 81,283 | 04-05-2022 |
News, Short Squeeze, Breakout and More Instantly...
Clearmind Medicine Inc. Company Name:
CMND:CC Stock Symbol:
CNQC Market:
Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated ...
Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a clinical- stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated hea...
Vancouver, Canada, April 09, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:CMND), (FSE: CWY0) (“Clearmind” or the “company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under...